Company / R&D Expense
Cooper Companies (The) R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$172.2M
FY2025
5-year range
$92.7M / $172.2M
FY2021-FY2025
Trend
+11.0%
vs FY2024
Sector context
#43 of 105
Health Care
What the data says
At $172M, Cooper Companies (The)'s r&d expense ranks #43 of 105 in the Health Care sector. R&D Expense has increased for 4 consecutive years, from $93M in FY2021 to $172M in FY2025.
Based on SEC 10-K filings.
$172M in FY2025 with a 5-year CAGR of +13.0%.
Improved from $137M to $172M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +16.0%
- 5-Year CAGR
- +13.0%
- 10-Year CAGR
- -
Sector benchmark
#43 of 105 in Health CareTop 41% of 105This company $172.2M Sector average $284.2M
▼
-39.4% below sector average
Key checks
Key Insights
- Cooper Companies (The)'s r&d expense has grown for 4 consecutive years.
- 5-year CAGR of +13.0%, indicating consistent growth.
- In FY2025, r&d expense increased 11.0% year-over-year.
- Ranks #43 out of 105 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $172.2M | +11.0% |
| FY2024 | $155.1M | +12.9% |
| FY2023 | $137.4M | +24.6% |
| FY2022 | $110.3M | +19.0% |
| FY2021 | $92.7M | -0.6% |
| FY2020 | $93.3M | +7.6% |
| FY2019 | $86.7M | +2.2% |
| FY2018 | $84.8M | +22.5% |
| FY2017 | $69.2M | +5.8% |
| FY2016 | $65.4M | -6.0% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026